Victorian Premier's Design Awards - Best in Category: Product Design
2024 Victorian Premier's Design Awards: Best in Category Product Design Award Winner - Neonav® ECG Tip Location System
Neonav® ECG Tip Location System: Best in Category Award: Product Design
Melbourne, Wednesday 20 November 2024 —
The very best Victorian designers, architects, and creatives were celebrated last night at the Victorian Premier’s Design Awards – the State’s highest honour for good design.
This year’s Best in Category Award for Product Design was presented to the Neonav® ECG Tip Location System, a groundbreaking medical device that addresses the critical challenge of accurately and safely placing central catheters to deliver essential medicines, nutrients, or fluids to critically ill newborns and children.
Developed by Melbourne-based Navi Medical Technologies, D+I Part of Capgemini, and in collaboration with the University of Melbourne and The Royal Women's Hospital, Neonav® is the result of an eight-year journey through a design-led, user-focused process prioritising safety, usability, and real-world clinical needs.
The Navi team dedicated countless hours in neonatal and paediatric intensive care units, observing life-saving procedures and working closely with clinical staff and industry experts to address challenges and to develop this innovative solution, which seeks to elevate the quality of care for one of our most vulnerable populations.
The Neonav® system has been realised with the support of Australian and Victorian medical research and commercialisation programs and has received international recognition, recently achieving FDA Breakthrough Device Designation.
Neonav® showcases the depth of Victoria’s talent and the capability of its people, demonstrating how collaboration between clinicians, researchers, designers, and engineers can transform concepts into real-world technologies that are destined to save lives.
Learn more: Navi Medical Technologies
(External Link)
Discover the Product Development Story - Navi Medical Technologies: Neonav® ECG Tip Location System
ISO 13485:2016 Quality Driven Medical Device Design + Development: Industrial Design, Mechanical Engineering, Electronics Design, Management into Production
Read More
About D+I Part of Capgemini
D+I Part of Capgemini is a design-driven, award-winning team with deep expertise in mechanical engineering and electronics product development. As a trusted partner in complete product development, D+I guides projects from research and discovery through to concept design, prototyping, and production, specialising in services across the product life cycle, including high-precision solutions with stringent compliance accreditation and certification requirements. As part of Capgemini’s global network, D+I is at the forefront of the intelligent industry, integrating physical and digital realms to create smart products that drive new value for clients by transforming ideas into commercially successful product solutions.
Contact:
+61 2 9555 1166
info@design-industry.com.au
Learn more about D+I
Learn more about Capgemini
Disclaimer:
The Neonav is currently under development and has not yet been cleared or approved by the U.S. Food and Drug Administration (FDA), Australian Therapeutic Goods Administration (TGA), or any other regulatory authority. All images and videos are intended for illustrative and educational purposes only. The Neonav is not available for commercial sale. The information provided herein is for informational purposes only and should not be construed as a promotional claim regarding the safety, efficacy, or intended use of the device. Any statements regarding potential benefits, uses, or features of the Neonav device are based on preliminary research and should not be interpreted as an endorsement by the FDA or TGA.
The Neonav is not available for sale or use in the United States or Australia until the necessary regulatory approvals and clearances have been obtained. We are committed to complying with all FDA and TGA requirements and will update our communications accordingly as we progress through the regulatory process.
